Hematocytopenia: Pancytopenia and Lineage-Specific Cytopenias
Hematocytopenia (more commonly termed pancytopenia when all three lineages are reduced) is a condition characterized by decreased numbers of one or more blood cell lines: erythrocytes (anemia), leukocytes (leukopenia), and/or platelets (thrombocytopenia).
Lineage-Specific Definitions
| Term | Cell Line | Key Threshold (Adults) |
|---|---|---|
| Anemia / Erythrocytopenia | Red blood cells / Hemoglobin | Hb <13 g/dL (M), <12 g/dL (F) |
| Leukopenia | Total white blood cells | <4,000/µL |
| Neutropenia | Neutrophils (ANC) | <1,500/µL (mild), <500/µL (severe) |
| Lymphopenia | Lymphocytes | <1,000/µL |
| Thrombocytopenia | Platelets | <150,000/µL |
Etiology (Mechanism-Based)
- Decreased production (bone marrow failure): Aplastic anemia, MDS, leukemia, infiltration (metastasis, fibrosis), nutritional (B12, folate, iron), toxins (benzene, chemo), viruses (parvovirus, HIV).
- Increased destruction/sequestration: Immune (ITP, AIHA, Evans), TTP/HUS, DIC, hypersplenism, mechanical (valves).
- Ineffective production: Megaloblastic anemia, myelodysplasia.
Clinical Presentation
- Anemia: Fatigue, pallor, dyspnea, tachycardia.
- Neutropenia: Fever, infections (mucosal, skin, sepsis).
- Thrombocytopenia: Petechiae, ecchymoses, mucosal bleeding, hemorrhage.
Diagnostic Workup
- CBC with differential, peripheral smear (morphology, blasts, schistocytes).
- Reticulocyte count (production vs. destruction).
- Bone marrow aspiration/biopsy (cellularity, dysplasia, infiltration).
- Targeted labs: B12, folate, iron, LDH, haptoglobin, Coombs, viral serologies, autoimmune panel.
Treatment Principles
- Treat underlying cause.
- Transfusion support (RBCs, platelets) for symptomatic/severe cytopenias.
- Growth factors: G-CSF (neutropenia), ESA (anemia), TPO agonists (thrombocytopenia).
- Immunosuppression (IST) for aplastic anemia, immune cytopenias.
- Stem cell transplant for refractory/severe marrow failure.
Leukemia - Related Articles
- 47,XYY Syndrome (Jacob’s Syndrome): Clinical Features and Management
- Leukemia Lifetime Risk: 1 in 2,065; More Common in Men and Children
- Childhood Leukemia Treatments: Understanding Options & Outlook
- Leukemia's Impact on the Circulatory System
- Autologous Stem Cell Therapy: How It Works & Benefits
- Sebaceous (Epidermal) Cysts: Features, Infection Signs, and Management
- Understanding Prolymphocytic Leukemia (PLL): Treatment Options & Outlook
